Hikma Pharmaceuticals PLC (HKMPF PINK) stock market data APIs
$23.6013
0(0%)
as of November 4, 2026
Try our APIs with
free plan!
Hikma Pharmaceuticals PLC Financial Data Overview
Price chart is built with
Anychart
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom.
Prev. Close
23.6013
Open
23.6013
High
23.6013
Low
23.6013
52 wk Range
15.6331-23.585
Market Cap
4 761 M
P/E Ratio
13.0682
Shares Outstanding
207 M
Revenue
3 419 M
EPS
0.5345
Dividends (Yield)
0.0389
Beta
0.627
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Hikma Pharmaceuticals PLC data using free add-ons & libraries
Get Hikma Pharmaceuticals PLC Fundamental Data
Hikma Pharmaceuticals PLC Fundamental data includes:
- Net Revenue: 3 419 M
- EBITDA: 879 M
- Earnings Per Share: 1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Hikma Pharmaceuticals PLC Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Hikma Pharmaceuticals PLC News
New
Hikma Pharmaceuticals And 2 British Biotech Stocks To Watch
AI enthusiasm in big tech is cooling as huge infrastructure budgets face tougher questions, which is pushing some investors to hunt beyond crowded US technology giants. That gives specialist British b...
3 British Biotech Stocks To Watch In October 2026
Union rule changes in the United Kingdom are set to increase employment costs for many businesses, which can pressure margins for sectors that rely heavily on large workforces. Biotech stocks in Brita...
3 British Biotech Stocks With Market Caps Up To £4 Billion
Britain is spending record sums just to keep its power grid stable, which shows how critical reliable energy and advanced health science have become to the country's future. That focus on resilience p...
Top 3 British Biotech Stocks To Watch In October 2026
Big Tech is pouring more than US$700b into AI infrastructure this year, and healthcare is one of the key testing grounds for whether that spending pays off. That puts British biotech shares in an intr...
Get Hikma Pharmaceuticals PLC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.